Antithrombotic Treatment and the Incidence of Angina Pectoris | Zendy

Christine Knottenbelt | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antithrombotic Treatment and the Incidence of Angina Pectoris

Author(s) -

Christine Knottenbelt

Publication year - 2002

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.162.8.881

Subject(s) - warfarin , aspirin , medicine , myocardial infarction , angina , placebo , unstable angina , cardiology , incidence (geometry) , antithrombotic , atrial fibrillation , physics , alternative medicine , pathology , optics

In primary prevention, anticoagulation with warfarin sodium to an international normalized ratio of 1.5 and 75 mg of aspirin per day each reduced the incidence of coronary heart disease (CHD). Effects on the development of angina pectoris and total CHD (resulting from angina, myocardial infarction, and coronary death) have been assessed, particularly in light of recent evidence that warfarin may have a "durable effect" on CHD through effects on the pathologic condition of the vessel walls involved.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research